| Original document(87 pages) 中文版 |
The invention relates to substituted, aryl-substituted heterocycles, the physiologically-acceptable salts and physiologically-functional derivatives thereof, methods for production and use thereof as medicaments. Compounds of formula (I), where the groups have the given meanings, the N-oxides and physiologically-acceptable salts thereof and methods for production thereof are disclosed. The compounds exhibit, for example a weight-reducing effect in mammals and are thus suitable for use in, for example, prevention and treatment of obesity and diabetes. Said compounds are MCH receptor antagonists. |
Application Number
申请号 |
200580009553 |
Application Date
申请日 |
2005.01.25 |
| Title 名称 |
Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
Publication Number
公开号 |
1934105 |
Publication Date
公开日 |
2007.03.21 |
| Approval Pub. Date |
|
Granted Pub. Date |
|
| International Classification 分类号 |
C07D413/10;C07D413/14;C07D417/14;C07D417/10;C07D491/113;A61K31/4245;A61P3/04;A61P3/10 |
Applicant(s) Name
申请人 |
Aventis Pharma GmbH |
| Address 地址 |
|
| Inventor(s) Name 发明人 |
|
| Attorney & Agent 代理人 |
huangge sheng anpei dong |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|